These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15916222)

  • 21. [Comparative study of the efficacy and tolerability of 0.1 and 0.03 p.100 adapalene gel and 0.025 p.100 tretinoin gel in the treatment of acne].
    Alirezai M; Meynadier J; Jablonska S; Czernielewski J; Verschoore M
    Ann Dermatol Venereol; 1996; 123(3):165-70. PubMed ID: 8761775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
    Gonzalez P; Vila R; Cirigliano M
    J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
    Thiboutot D; Gold MH; Jarratt MT; Kang S; Kaplan DL; Millikan L; Wolfe J; Loesche C; Baker M
    Cutis; 2001 Oct; 68(4 Suppl):10-9. PubMed ID: 11845943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adapalene 0.1% and benzoyl peroxide 2.5% as a fixed-dose combination gel is as well tolerated as the individual components alone in terms of cumulative irritancy.
    Loesche C; Pernin C; Poncet M
    Eur J Dermatol; 2008; 18(5):524-6. PubMed ID: 18693154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
    Thiboutot D; Arsonnaud S; Soto P
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s3-10. PubMed ID: 18575220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term safety and efficacy study of adapalene 0.3% gel.
    Weiss JS; Thiboutot DM; Hwa J; Liu Y; Graeber M
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s24-8. PubMed ID: 18575223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.
    Capizzi R; Landi F; Milani M; Amerio P
    Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents.
    Brand B; Gilbert R; Baker MD; Poncet M; Greenspan A; Georgeian K; Soloff AM
    J Am Acad Dermatol; 2003 Sep; 49(3 Suppl):S227-32. PubMed ID: 12963899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adapalene 0.1% gel and adapalene 0.1% cream stimulate retinoic acid receptor mediated gene transcription without significant irritative effects in the skin of healthy human volunteers.
    Griffiths CE; Ancian P; Humphries J; Poncet M; Rizova E; Michel S; Clucas A
    Br J Dermatol; 1998 Oct; 139 Suppl 52():12-6. PubMed ID: 9990415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy, safety, and tolerability of microsphere adapalene vs. conventional adapalene for acne vulgaris.
    Rao GR; Ghosh S; Dhurat R; Sharma A; Dongre P; Baliga VP
    Int J Dermatol; 2009 Dec; 48(12):1360-5. PubMed ID: 20415678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris.
    Ellis CN; Millikan LE; Smith EB; Chalker DM; Swinyer LJ; Katz IH; Berger RS; Mills OH; Baker M; Verschoore M; Loesche C
    Br J Dermatol; 1998 Oct; 139 Suppl 52():41-7. PubMed ID: 9990420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical retinoids in acne--an evidence-based overview.
    Thielitz A; Abdel-Naser MB; Fluhr JW; Zouboulis CC; Gollnick H
    J Dtsch Dermatol Ges; 2008 Dec; 6(12):1023-31. PubMed ID: 18479477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tolerability comparison of adapalene gel, 0.3% versus tazarotene cream, 0.05% in subjects with healthy skin.
    Dosik JS; Arsonnaud S
    J Drugs Dermatol; 2007 Jun; 6(6):632-8. PubMed ID: 17668529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative irritancy study among retinoid creams and gels.
    Toole JW; Lockhart L; Potrebka J; Bowman JP; Novack GD
    J Cutan Med Surg; 1999 Oct; 3(6):298-301. PubMed ID: 10575158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative evaluation of tretinoin gel microsphere, 0.1%, versus tretinoin cream, 0.025%, in reducing facial shine.
    Nyirady J; Nighland M; Payonk G; Pote J; Phillips S; Grossman R
    Cutis; 2000 Aug; 66(2):153-6. PubMed ID: 10955199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.
    Tanghetti E; Dhawan S; Green L; Del Rosso J; Draelos Z; Leyden J; Shalita A; Glaser DA; Grimes P; Webster G; Barnett P; Le Gall N
    J Drugs Dermatol; 2010 May; 9(5):549-58. PubMed ID: 20480800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants.
    Andres P; Pernin C; Poncet M
    Cutis; 2008 Mar; 81(3):278-84. PubMed ID: 18441854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adapalene 0.1% gel has low skin-irritation potential.
    Verschoore M; Poncet M; Czernielewski J; Sorba V; Clucas A
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 2):S104-9. PubMed ID: 9204086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.
    Webster GF; Guenther L; Poulin YP; Solomon BA; Loven K; Lee J
    Cutis; 2002 Feb; 69(2 Suppl):4-11. PubMed ID: 12095066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.